taxonomy (1)
protein (1)
source (3)
structure (0)
composition (17)
disease (2)
reference (4)
site (4)
peptide (3)
- Homo sapiens (Human)
Taxonomy
- Protein yipf3 / Homo sapiens Q9GZM5
Protein
- Mammary Gland (UBERON_0001911)
- Urine (UBERON_0001088)
- Cerebrospinal Fluid Secretion (GO_0033326)
Source
Reported structure
- HexNAc:1 (avg mass : 221.2103 )
- Hex:1 HexNAc:1 (avg mass : 383.3527 )
- Hex:1 HexNAc:1 NeuAc:1 (avg mass : 674.6106 )
- Hex:1 HexNAc:1 NeuAc:1 NeuGc:1 (avg mass : 981.8679 )
- Hex:1 HexNAc:1 NeuAc:2 (avg mass : 965.8685 )
- Hex:1 HexNAc:2 (avg mass : 586.5477 )
- Hex:2 HexNAc:2 (avg mass : 748.6901 )
- Hex:2 HexNAc:2 NeuAc:2 (avg mass : 1331.2059 )
- Hex:2 HexNAc:2 dHex:1 (avg mass : 894.8331 )
- Hex:2 HexNAc:2 dHex:1 NeuAc:2 (avg mass : 1477.3489 )
- Hex:6 HexNAc:4 NeuAc:1 (avg mass : 2094.9076 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 NeuGc:1 (avg mass : 3042.7608 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 (avg mass : 3026.7614 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:3 (avg mass : 3392.0988 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:4 (avg mass : 3683.3567 )
- Hex:7 HexNAc:7 dHex:1 NeuAc:2 NeuGc:1
- Hex:8 HexNAc:7 dHex:1 NeuAc:1 NeuGc:1
Composition
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- LC-MS/MS characterization of O-glycosylation sites and glycan structures of human cerebrospinal fluid glycoproteins (2013 - Halim A, Rüetschi U, Larson G, Nilsson J) / Status : Reviewed
- Human urinary glycoproteomics; attachment site specific analysis of N- and O-linked glycosylations by CID and ECD (2012 - Halim A, Nilsson J, Rüetschi U, Hesse C, Larson G) / Status : Reviewed
Reference
- Protein yipf3 / Homo sapiens
Reported glycosite
- LPTTVLNATAK (11aa)
- LNATAK (6aa)
- AVAVTLQSH (9aa)
- AVAVTLQSH (9aa)
Mass spectrometry observed peptide
-
- HexNAc:1 / O-Linked (avg mass : 221.2103)
- Urine (UBERON_0001088)
- Protein yipf3 / Homo sapiens
-
- Hex:1 HexNAc:1 / O-Linked (avg mass : 383.3527)
- LC-MS/MS characterization of O-glycosylation sites and glycan structures of human cerebrospinal fluid glycoproteins (2013 - Halim A, Rüetschi U, Larson G, Nilsson J) / Status : Reviewed
- Human urinary glycoproteomics; attachment site specific analysis of N- and O-linked glycosylations by CID and ECD (2012 - Halim A, Nilsson J, Rüetschi U, Hesse C, Larson G) / Status : Reviewed
- Protein yipf3 / Homo sapiens
-
- Hex:1 HexNAc:2 / O-Linked (avg mass : 586.5477)
- Urine (UBERON_0001088)
- Protein yipf3 / Homo sapiens
-
- Hex:1 HexNAc:1 NeuAc:1 / O-Linked (avg mass : 674.6106)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Protein yipf3 / Homo sapiens
- AVAVTLQSH (9aa)
- AVAVTLQSH (9aa)
-
- Hex:2 HexNAc:2 / O-Linked (avg mass : 748.6901)
- Urine (UBERON_0001088)
- Protein yipf3 / Homo sapiens
-
- Hex:2 HexNAc:2 dHex:1 / O-Linked (avg mass : 894.8331)
- Urine (UBERON_0001088)
- Protein yipf3 / Homo sapiens
-
- Hex:1 HexNAc:1 NeuAc:2 / O-Linked (avg mass : 965.8685)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Protein yipf3 / Homo sapiens
- AVAVTLQSH (9aa)
- AVAVTLQSH (9aa)
-
- Hex:1 HexNAc:1 NeuAc:1 NeuGc:1 / O-Linked (avg mass : 981.8679)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Protein yipf3 / Homo sapiens
- AVAVTLQSH (9aa)
- AVAVTLQSH (9aa)
-
- Hex:2 HexNAc:2 NeuAc:2 / O-Linked (avg mass : 1331.2059)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Protein yipf3 / Homo sapiens
- AVAVTLQSH (9aa)
- AVAVTLQSH (9aa)
-
- Hex:2 HexNAc:2 dHex:1 NeuAc:2 / O-Linked (avg mass : 1477.3489)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Protein yipf3 / Homo sapiens
- AVAVTLQSH (9aa)
- AVAVTLQSH (9aa)
-
- Hex:6 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 2094.9076)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Protein yipf3 / Homo sapiens
- LNATAK (6aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 / N-Linked (avg mass : 3026.7614)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Protein yipf3 / Homo sapiens
- LPTTVLNATAK (11aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 NeuGc:1 / N-Linked (avg mass : 3042.7608)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Protein yipf3 / Homo sapiens
- LPTTVLNATAK (11aa)
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:3 / N-Linked (avg mass : 3392.0988)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Protein yipf3 / Homo sapiens
- LPTTVLNATAK (11aa)
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:4 / N-Linked (avg mass : 3683.3567)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Protein yipf3 / Homo sapiens
- LPTTVLNATAK (11aa)
-
- Hex:7 HexNAc:7 dHex:1 NeuAc:2 NeuGc:1 / N-Linked
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Protein yipf3 / Homo sapiens
- LPTTVLNATAK (11aa)
-
- Hex:8 HexNAc:7 dHex:1 NeuAc:1 NeuGc:1 / N-Linked
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Protein yipf3 / Homo sapiens
- LPTTVLNATAK (11aa)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
